This inventor holds 1 USPTO granted patent. Top assignee: Schering Aktiengesellschaft. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Walther Birkmayer: Innovator in Parkinson's Disease Treatment
Introduction
Walther Birkmayer is a notable inventor based in Vienna, Austria. He is recognized for his significant contributions to the field of medicine, particularly in the treatment of Parkinson's disease. His innovative approach has led to the development of a unique treatment method that utilizes a specific enzyme cofactor.
Latest Patents
Birkmayer holds a patent for an agent used in the treatment of Parkinson's disease. The patent details the use of nicotinamide adenine dinucleotide or a salt thereof as a therapeutic agent. This invention aims to provide a new avenue for managing the symptoms associated with Parkinson's disease.
Career Highlights
Throughout his career, Walther Birkmayer has been associated with Schering Aktiengesellschaft, a prominent pharmaceutical company. His work has focused on advancing medical treatments and improving patient outcomes in neurodegenerative diseases.
Collaborations
Birkmayer has collaborated with notable colleagues, including Jorg Birkmayer and Reinhard Horowski. These partnerships have contributed to the development and refinement of his innovative treatment methods.
Conclusion
Walther Birkmayer's contributions to the treatment of Parkinson's disease highlight his role as a pioneering inventor in the medical field. His patent for the use of nicotinamide adenine dinucleotide represents a significant advancement in therapeutic options for patients.